Model-based preclinical development of anti-tuberculosis drug combinations
Site Search
Site Search
Displaying results 191 - 200 of 472
Harmonised approach to early feasibility studies for medical devices in the European Union
14/07/2023
Results from the COMBACTE-CARE project show that – if approved – a new combination of drugs could help in the fight against some of the most dangerous drug-resistant bacteria.
04/05/2023
Data gathered during IMI project DIRECT helped scientists to pinpoint genetic variants associated with a good response to diabetes drugs called GLP-1 agonists.
06/07/2022
The joint undertakings are about creating public-private partnerships (PPPs) – and IHI is no exception. In an interview, the European Commission’s Irene Norstedt, chair of the...
11/03/2024
The papers in Frontiers in Neurology demonstrate how public-private collaborative research through IMI and now IHI is making a difference in the Alzheimer’s disease field.
Medical innovation has often been slow to trickle down to children and adolescents. IHI and IMI's paediatric research portfolios are changing that.
29/08/2023
IMAGIO focuses on ‘interventional oncology’, which uses miniaturised instruments to target cancer cells more precisely, thereby sparing health cells.
23/10/2024
The new IHI project aims to address gaps along the whole stroke care pathway, from diagnosis and emergency treatment, to rehabilitation and the prevention of further strokes.